Almirall (FRA:E2Z) Accounts Payable & Accrued Expense : €0.0 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Almirall Accounts Payable & Accrued Expense?

Almirall's quarterly accounts payable & accrued expense declined from Jun. 2023 (€216.9 Mil) to Dec. 2023 (€212.8 Mil) and declined from Dec. 2023 (€212.8 Mil) to Mar. 2024 (€0.0 Mil).

Almirall's annual accounts payable & accrued expense increased from Dec. 2021 (€199.6 Mil) to Dec. 2022 (€213.3 Mil) but then declined from Dec. 2022 (€213.3 Mil) to Dec. 2023 (€212.8 Mil).

Almirall Accounts Payable & Accrued Expense Historical Data

The historical data trend for Almirall's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Accounts Payable & Accrued Expense Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

264.49

213.98

199.59

213.31

212.80

Almirall Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															213.31	-	216.85	212.80	-

Almirall Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Almirall (FRA:E2Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (FRA:E2Z) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

LBTSF:USA 0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (FRA:E2Z) Headlines

No Headlines